{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:13:43Z","timestamp":1790115223370,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,12,17]],"date-time":"2010-12-17T00:00:00Z","timestamp":1292544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s10067-010-1649-2","type":"journal-article","created":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T03:44:28Z","timestamp":1292471068000},"page":"757-763","source":"Crossref","is-referenced-by-count":37,"title":["Visfatin levels and intima-media thicknesses in rheumatic diseases"],"prefix":"10.1007","volume":"30","author":[{"given":"Metin","family":"Ozgen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleyman Serdar","family":"Koca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kader","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necati","family":"Dagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Ustundag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Isik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,17]]},"reference":[{"key":"1649_CR1","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","volume":"108","author":"N Sattar","year":"2003","unstructured":"Sattar N, McCarey DW, Capell H, McInnes IB (2003) Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108:2957\u20132963","journal-title":"Circulation"},{"key":"1649_CR2","first-page":"1072","volume":"25","author":"DP Symmons","year":"1998","unstructured":"Symmons DP, Jones MA, Scott DL, Prior P (1998) Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol 25:1072\u20131077","journal-title":"J Rheumatol"},{"key":"1649_CR3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U","volume":"42","author":"MM Ward","year":"1999","unstructured":"Ward MM (1999) Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 42:338\u2013346","journal-title":"Arthritis Rheum"},{"key":"1649_CR4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/art.23196","volume":"58","author":"T Thompson","year":"2008","unstructured":"Thompson T, Sutton-Tyrrell K, Wildman RP et al (2008) Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus. Arthritis Rheum 58:835\u2013842","journal-title":"Arthritis Rheum"},{"key":"1649_CR5","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/ar2408","volume":"10","author":"ME Hettema","year":"2008","unstructured":"Hettema ME, Zhang D, de Leeuw K et al (2008) Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors. Arthritis Res Ther 10:R49","journal-title":"Arthritis Res Ther"},{"key":"1649_CR6","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00296-005-0098-8","volume":"26","author":"MA Ozt\u00fcrk","year":"2006","unstructured":"Ozt\u00fcrk MA, Oktar SO, Unverdi S et al (2006) Morphologic evidence of subclinical atherosclerosis obtained by carotid ultrasonography in patients with Behcet\u2019s disease. Rheumatol Int 26:867\u2013872","journal-title":"Rheumatol Int"},{"key":"1649_CR7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/ar2631","volume":"11","author":"LE Full","year":"2009","unstructured":"Full LE, Ruisanchez C, Monaco C (2009) The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 11:217","journal-title":"Arthritis Res Ther"},{"key":"1649_CR8","first-page":"23","volume":"9","author":"SS Koca","year":"2009","unstructured":"Koca SS, Karaca I, Yavuzkir MF et al (2009) Insulin resistance is related with oxidative stress in systemic lupus erythematosus. Anadolu Kardiyol Derg 9:23\u201328","journal-title":"Anadolu Kardiyol Derg"},{"key":"1649_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/en.130.1.43","volume":"130","author":"CH Lang","year":"1992","unstructured":"Lang CH, Dobrescu C, Bagby GJ (1992) Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130:43\u201352","journal-title":"Endocrinology"},{"key":"1649_CR10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/oby.2001.54","volume":"9","author":"B Vozarova","year":"2001","unstructured":"Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE (2001) Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9:414\u2013417","journal-title":"Obes Res"},{"key":"1649_CR11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1210\/er.2002-0010","volume":"24","author":"JM Fern\u00e1ndez-Real","year":"2003","unstructured":"Fern\u00e1ndez-Real JM, Ricart W (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24:278\u2013301","journal-title":"Endocr Rev"},{"key":"1649_CR12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.22482","volume":"57","author":"MA Gonzalez-Gay","year":"2007","unstructured":"Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ et al (2007) HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 57:125\u2013132","journal-title":"Arthritis Rheum"},{"key":"1649_CR13","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1128\/MCB.14.2.1431","volume":"14","author":"B Samal","year":"1994","unstructured":"Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I (1994) Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 14:1431\u20131437","journal-title":"Mol Cell Biol"},{"key":"1649_CR14","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","volume":"178","author":"AR Moschen","year":"2007","unstructured":"Moschen AR, Kaser A, Enrich B et al (2007) Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178:1748\u20131758","journal-title":"J Immunol"},{"key":"1649_CR15","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1067\/mob.2002.126295","volume":"187","author":"S Ognjanovic","year":"2002","unstructured":"Ognjanovic S, Bryant-Greenwood GD (2002) Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol 187:1051\u20131058","journal-title":"Am J Obstet Gynecol"},{"key":"1649_CR16","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI19930","volume":"113","author":"SH Jia","year":"2004","unstructured":"Jia SH, Li Y, Parodo J et al (2004) Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 113:1318\u20131327","journal-title":"J Clin Invest"},{"key":"1649_CR17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1164\/rccm.200404-563OC","volume":"171","author":"SQ Ye","year":"2005","unstructured":"Ye SQ, Simon BA, Maloney JP et al (2005) Pre-B cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 171:361\u2013370","journal-title":"Am J Respir Crit Care Med"},{"key":"1649_CR18","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1136\/ard.2005.046540","volume":"65","author":"M Otero","year":"2006","unstructured":"Otero M, Lago R, Gomez R et al (2006) Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65:1198\u20131201","journal-title":"Ann Rheum Dis"},{"key":"1649_CR19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","volume":"307","author":"A Fukuhara","year":"2005","unstructured":"Fukuhara A, Matsuda M, Nishizawa M et al (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426\u2013430","journal-title":"Science"},{"key":"1649_CR20","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.2337\/diabetes.54.10.2911","volume":"54","author":"J Berndt","year":"2005","unstructured":"Berndt J, Kl\u00f6ting N, Kralisch S et al (2005) Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54:2911\u20132916","journal-title":"Diabetes"},{"key":"1649_CR21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/jc.2005-1475","volume":"91","author":"MP Chen","year":"2006","unstructured":"Chen MP, Chung FM, Chang DM et al (2006) Elevated plasma level of visfatin\/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 91:295\u2013299","journal-title":"J Clin Endocrinol Metab"},{"key":"1649_CR22","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.bbamcr.2008.01.004","volume":"1783","author":"SR Kim","year":"2008","unstructured":"Kim SR, Bae YH, Bae SK et al (2008) Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells. Biochim Biophys Acta 1783:886\u2013895","journal-title":"Biochim Biophys Acta"},{"key":"1649_CR23","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/CIRCULATIONAHA.106.665893","volume":"115","author":"TB Dahl","year":"2007","unstructured":"Dahl TB, Yndestad A, Skjelland M et al (2007) Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 115:972\u2013980","journal-title":"Circulation"},{"key":"1649_CR24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"1649_CR25","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"1649_CR26","first-page":"1573","volume":"28","author":"EC LeRoy","year":"2001","unstructured":"LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573\u20131576","journal-title":"J Rheumatol"},{"key":"1649_CR27","first-page":"1078","volume":"335","author":"International Study Group for Behcet\u2019s Disease","year":"1990","unstructured":"International Study Group for Behcet\u2019s Disease (1990) Criteria for diagnosis of Behcet\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"1649_CR28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/art.20923","volume":"53","author":"BF Leeb","year":"2005","unstructured":"Leeb BF, Andel I, Sautner J et al (2005) Disease activity measurement of rheumatoid arthritis: comparison of the simplified disease activity index (SDAI) and the disease activity score including 28 joints (DAS28) in daily routine. Arthritis Rheum 53:56\u201360","journal-title":"Arthritis Rheum"},{"key":"1649_CR29","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630\u2013640","journal-title":"Arthritis Rheum"},{"key":"1649_CR30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","volume":"39","author":"D Gladman","year":"1996","unstructured":"Gladman D, Ginzler E, Goldsmith C et al (1996) The development and initial validation of the systemic lupus international collaborating clinics\/American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363\u2013369","journal-title":"Arthritis Rheum"},{"key":"1649_CR31","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/ard.60.6.585","volume":"60","author":"A Della Rossa","year":"2001","unstructured":"Della Rossa A, Valentini G, Bombardieri S et al (2001) European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis 60:585\u2013591","journal-title":"Ann Rheum Dis"},{"key":"1649_CR32","first-page":"2159","volume":"26","author":"TA Medsger Jr","year":"1999","unstructured":"Medsger TA Jr, Silman AJ, Steen VD et al (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159\u20132167","journal-title":"J Rheumatol"},{"key":"1649_CR33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1620\/tjem.212.133","volume":"212","author":"A Isik","year":"2007","unstructured":"Isik A, Koca SS, Ustundag B, Selek S (2007) Decreased total antioxidant response and increased oxidative stress in Behcet\u2019s disease. Tohoku J Exp Med 212:133\u2013141","journal-title":"Tohoku J Exp Med"},{"key":"1649_CR34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"1649_CR35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cytogfr.2007.04.007","volume":"18","author":"F Lago","year":"2007","unstructured":"Lago F, Dieguez C, Gomez-Reino J, Gualillo O (2007) The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 18:313\u2013325","journal-title":"Cytokine Growth Factor Rev"},{"key":"1649_CR36","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/jc.2006-0361","volume":"91","author":"C Pagano","year":"2006","unstructured":"Pagano C, Pilon C, Olivieri M et al (2006) Reduced plasma visfatin\/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab 91:3165\u20133170","journal-title":"J Clin Endocrinol Metab"},{"key":"1649_CR37","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s00125-006-0173-z","volume":"49","author":"CA Curat","year":"2006","unstructured":"Curat CA, Wegner V, Sengen\u00e8s C et al (2006) Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 49:744\u2013747","journal-title":"Diabetologia"},{"key":"1649_CR38","first-page":"56","volume":"28","author":"MA Gonzalez-Gay","year":"2010","unstructured":"Gonzalez-Gay MA, Vazquez-Rodriguez TR, Garcia-Unzueta MT et al (2010) Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy. Clin Exp Rheumatol 28:56\u201362","journal-title":"Clin Exp Rheumatol"},{"key":"1649_CR39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3899\/jrheum.080503","volume":"36","author":"M Vadacca","year":"2009","unstructured":"Vadacca M, Margiotta D, Rigon A et al (2009) Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors. J Rheumatol 36:295\u2013297","journal-title":"J Rheumatol"},{"key":"1649_CR40","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/art.22833","volume":"56","author":"F Brentano","year":"2007","unstructured":"Brentano F, Schorr O, Ospelt C et al (2007) Pre-B cell colony-enhancing factor\/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum 56:2829\u20132839","journal-title":"Arthritis Rheum"},{"key":"1649_CR41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1172\/JCI115872","volume":"90","author":"S Lacraz","year":"1992","unstructured":"Lacraz S, Nicod L, Galve-de Rochemonteix B, Baumberger C, Dayer JM, Welgus HG (1992) Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest 90:382\u2013388","journal-title":"J Clin Invest"},{"key":"1649_CR42","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.4049\/jimmunol.161.6.3071","volume":"161","author":"Y Zhang","year":"1998","unstructured":"Zhang Y, McCluskey K, Fujii K, Wahl LM (1998) Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. J Immunol 161:3071\u20133076","journal-title":"J Immunol"},{"key":"1649_CR43","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bbrc.2007.12.131","volume":"367","author":"EK Song","year":"2008","unstructured":"Song EK, Lee YR, Yu HN et al (2008) Extracellular NAD is a regulator for FcgammaR-mediated phagocytosis in murine macrophages. Biochem Biophys Res Commun 367:156\u2013161","journal-title":"Biochem Biophys Res Commun"},{"key":"1649_CR44","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1084\/jem.174.6.1549","volume":"174","author":"C Bogdan","year":"1991","unstructured":"Bogdan C, Vodovotz Y, Nathan C (1991) Macrophage deactivation by interleukin 10. J Exp Med 174:1549\u20131555","journal-title":"J Exp Med"},{"key":"1649_CR45","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/art.24626","volume":"60","author":"YH Rho","year":"2009","unstructured":"Rho YH, Solus J, Sokka T et al (2009) Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 60:1906\u20131914","journal-title":"Arthritis Rheum"},{"key":"1649_CR46","first-page":"70","volume":"25","author":"S Pay","year":"2007","unstructured":"Pay S, Abbasov T, Erdem H et al (2007) Serum MMP-2 and MMP-9 in patients with Beh\u00e7et\u2019s disease: do their higher levels correlate to vasculo-Beh\u00e7et\u2019s disease associated with aneurysm formation? Clin Exp Rheumatol 25:70\u201375","journal-title":"Clin Exp Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1649-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-010-1649-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1649-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T14:19:44Z","timestamp":1685888384000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-010-1649-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,17]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["1649"],"URL":"https:\/\/doi.org\/10.1007\/s10067-010-1649-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,17]]}}}